Abstract
Purpose of Review: The purpose of this review is to discuss the current and emerging treatment options of food allergy. Recent Findings: The mainstay of treatment for food allergy was traditionally avoidance and/or symptomatic antihistamine and adrenaline treatment depending on severity of symptoms. In the past two decades, allergen-specific immunotherapy and biologic therapies have emerged as treatment options to increase the threshold of reactivity to specific food allergens. Allergen-specific approaches include oral, sublingual, subcutaneous, and epicutaneous immunotherapy as well as DNA vaccines. Monoclonal antibodies blocking IgE and IL-4/IL-13 receptors are being investigated as monotherapy and as combined therapy with allergen specific immunotherapy. Summary: While oral immunotherapy is best studied and has led to an FDA approved therapy for patients between 4 and 17 years old (Palforzia™), many of the other immunotherapies as well as biologics are still in early stages of clinical trials.
Original language | English |
---|---|
Pages (from-to) | 319-339 |
Number of pages | 21 |
Journal | Current Treatment Options in Allergy |
Volume | 10 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2023 |
Externally published | Yes |
Keywords
- Allergen
- Food allergy
- Immunotherapy